IDENTIFICATION AND ANALYSIS OF DRUG-RELATED PROBLEMS INCIDENCE AT HOSPITALIZED PATIENTS IN HAJI REGIONAL GENERAL HOSPITAL, MAKASSAR

MUHAMMAD ALDILA SATRIA; SUDIBYO SUPARDI

doi:10.22159/ajpcr.2021.v14i3.40391

Authors

MUHAMMAD ALDILA SATRIA Department of Pharmaceutical Science, Faculty of Pharmacy, University of Indonesia, Depok, West Java, Indonesia,
SUDIBYO SUPARDI Department of Health Resources, National Institute of Health Research and Development, Indonesian Ministry of Health, Jakarta, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i3.40391

Keywords:

Identification, Drug-related problem, Patient treatment

Abstract

Objective: This study aims to identify inpatient medication problems and analyze the association between patient characteristics and the incidence of the drug-related problem (DRP) experienced by patients.

Methods: The cross-sectional study was conducted at Haji Regional General Hospital, Makassar, using medical record data for inpatients from January to February 2020. Data were collected from September to October 2020. A total of 247 inpatients were identified using the Indonesian version of the Pharmaceutical Care Network Europe.

Results: The most common DRP problem found is the effect of drug treatment not optimal (P1.2) by 35.76% and the most common cause found is no or incomplete drug treatment despite existing indication (C1.6) by 20.16%. Bivariate analysis shows that age, length of stay, and the number of drugs received are significant different with the incidence of DRP in patients (p < 0,01) respectively. Multivariate analysis using logistic regression shows that age, sex, and the number of drugs could significantly affect the incidence of DRP (p<0.05) with the r-square (R2) of 21.6%. According to this model, the largest odds ratio number and the most likely to experience DRP in a patient are age, the number of drugs, then gender (5,2; 4,6; and 2,3).

Conclusion: Age, length of stay, and the number of drugs received affect the DRP incidence in a patient, while gender together with age and the number of drugs affecting the incidence of DRP in a patient.

Downloads

Download data is not yet available.

References

van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859-67.

Rikomah SE. Farmasi Klinik. Yogyakarta: Deepublish Publisher; 2016.

Al-Azzam SI, Alzoubi KH, Alefan Q, Alzayadeen RN. Evaluation of the types and frequency of DRP and the association with gender in patients with chronic diseases attending a primary health care center in Jordan. Int Health 2016;8:423-6.

Abu Farha RK, Mukattash TL, Qudah R, Alkhalaileh W, Alsaffar S. DRP and health-related quality of life in outpatients with Type 2 diabetes: A cross-sectional study from Jordan. J Pharm Health Serv Res 2019;10:303-9.

Hsu KL, Fink JC, Ginsberg JS, Yoffe M, Zhan M, Fink W, et al. Self-reported medication adherence and adverse patient safety events in CKD. Am J Kidney Dis 2015;66:621-9.

Kovačević SV, Miljković B, Ćulafić M, Kovačević M, Golubović B, Jovanović M, et al. Evaluation of DRPin older polypharmacy primary care patients. J Eval Clin Pract 2017;23:860-5.

Ramadaniati HU, Anggriani Y, Wowor VM, Rianti A. DRPin chronic kidneys disease patients in an Indonesian hospital: Do the problems really matter? Int J Pharm Pharm Sci 2016;8:298-302.

Zazuli Z, Rohaya A, Adnyana KI. DRPin Type 2 diabetic patients with hypertension: A prospective study. Int J Green Pharm 2017;11:298-304.

Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and DRP among coronary heart disease inpatients: A pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J 2018;18:e81-7.

Dahlan, S. Statistik Untuk Kedokteran dan Kesehatan. 6th ed. Jakarta: Epidemiologi Indonesia; 2014.

Herman MJ, Sari ID. Analisis MTO di lima rumah sakit tahun 2010. J Ilmu Kefarmasian Indones 2012;10:163-9.

Saldanha V, Martins RR, Lima SI, de Araujo IB, Oliveira AG. Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort. BMJ Open 2020;10:1-8.

Abunahlah N, Elawaisi A, Velibeyoglu FM, Sancar M. Drug related problems identified by clinical pharmacist at the internal medicine ward in Turkey. Int J Clin Pharm 2018;40:360-7.

Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, et al. Analysis of DRPin three departments of a German University hospital. Int J Clin Pharm 2016;38:119-26.

Modesto AC, Ribeiro AM, Pereira JL, Silva LT, Provin MP, Ferreira PS, et al. Evaluation of a method for DRP identification and classification in hospital setting: Applicability and reliability. Int J Clin Pharm 2020;42:193-200.

Peterson C, Gustafsson M. Characterisation of DRP and Associated factors at a clinical pharmacist service-naïve hospital in Northern Sweden. Drugs Real World Outcomes 2017;4:97-107.